USPTO Deadlines
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 20, 2010 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | Loading... |
| Jan 20, 2010 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Jan 20, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 20, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 19, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 12, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 11, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 11, 2009 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 11, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 11, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 16, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 15, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders -- Electrical producing pharmaceutical preparations in the form of topical analgesic medication both veterinary and human preparations, namely, in the forms of creams, lotions, gels and solids as to increase metabolism, increase metabolic system function, increase circulation and enhance nerve functions; to relieve symptoms of diabetic neuropathy, post hepatic neuralgia, scleroderma, psoriasis, tissue strains, tissue spasms, spasticity, headaches, neuropathy secondary to drugs, peripheral neuropathy, leg pain, muscle cramps, muscle aches, muscle pains, bruises, sinusitis, sprain, arthritis, joint pain, edema, restless leg syndrome, multiple sclerosis, muscular and nerve deficient symptoms, spinal chord injuries, stress and deficient wrinkles in skin due to insufficient nerve and vascular circulation
First Use Anywhere:
Jun 11, 2009
First Use in Commerce:
Jun 11, 2009
Classification
International Classes
005